There is new evidence that some children may become very sick, and we are beginning to learn more about who may be most at risk and what parents need to watch for.
As COVID-19-related drug shortages continue to persist in the EU, regulators explore the possibility of drawing lessons from existing models that member states use to estimate national demand for medicines.